Debnath, S.K.; Debnath, M.; Ghosh, A.; Srivastava, R.; Omri, A.
Targeting Tumor Hypoxia with Nanoparticle-Based Therapies: Challenges, Opportunities, and Clinical Implications. Pharmaceuticals 2024, 17, 1389.
https://doi.org/10.3390/ph17101389
AMA Style
Debnath SK, Debnath M, Ghosh A, Srivastava R, Omri A.
Targeting Tumor Hypoxia with Nanoparticle-Based Therapies: Challenges, Opportunities, and Clinical Implications. Pharmaceuticals. 2024; 17(10):1389.
https://doi.org/10.3390/ph17101389
Chicago/Turabian Style
Debnath, Sujit Kumar, Monalisha Debnath, Arnab Ghosh, Rohit Srivastava, and Abdelwahab Omri.
2024. "Targeting Tumor Hypoxia with Nanoparticle-Based Therapies: Challenges, Opportunities, and Clinical Implications" Pharmaceuticals 17, no. 10: 1389.
https://doi.org/10.3390/ph17101389
APA Style
Debnath, S. K., Debnath, M., Ghosh, A., Srivastava, R., & Omri, A.
(2024). Targeting Tumor Hypoxia with Nanoparticle-Based Therapies: Challenges, Opportunities, and Clinical Implications. Pharmaceuticals, 17(10), 1389.
https://doi.org/10.3390/ph17101389